The duration of axillary lymphadenopathy detected by breast ultrasound after COVID-19 mRNA vaccination is longer than previously reported in initial vaccine clinical trials. A new research published in ARRS' American Journal of Roentgenology (AJR) shows that axillary lymphadenopathy detected by b